Amylin Pharmaceuticals (AMLN +18.7%) jumps after the FDA approved Bydureon, its weekly treatment for diabetes, on Friday. Alkermes (ALKS +0.8%), its partner on the drug, is also up on heavy volume.
Amylin Pharmaceuticals (AMLN +18.7%) jumps after the FDA approved Bydureon, its weekly treatment...
Recommended For You
More Trending News
About BMY Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| BMY | - | - |
| Bristol-Myers Squibb Company | ||